PCSK9 genetic deletion or using PCSK9 antibodies enhanced the major histocompatibility protein class I expression on the tumor cell surface, enabling CD8 T cells to identify cancer cells and improving the cytotoxic T cells’ intratumoral infiltration [23]. The gene discussed is CD8A; the disease is cancer.